Đang chuẩn bị liên kết để tải về tài liệu:
Malignancy risk in Australian rheumatoid arthritis patients treated with anti-tumour necrosis factor therapy: Analysis of the Australian Rheumatology Association Database (ARAD) prospective cohort study

Không đóng trình duyệt đến khi xuất hiện nút TẢI XUỐNG

Malignancy risk with tumour necrosis factor inhibitor (TNFi) therapy remains unclear. Our primary aim was to assess malignancy risk with TNFi therapy in a cohort of Australian patients with rheumatoid arthritis (RA). We also assessed risk in a biologic-naïve group. |

TÀI LIỆU LIÊN QUAN

Investigating the performance and costeffectiveness of the simple ultrasound-based rules compared to the risk of malignancy index in the diagnosis of ovarian cancer (SUBSONiC-study): Protocol of a prospective multicenter cohort study in the Netherlands

Development and validation of a model that includes two ultrasound parameters and the plasma D-dimer level for predicting malignancy in adnexal masses: An observational study

Increased risk of lymphoid malignancy in patients with herpes zoster: A longitudinal follow-up study using a national cohort

Site disparities in apoptotic variants as predictors of risk for second primary malignancy in patients with squamous cell carcinoma of the head and neck

Malignancy risk in Australian rheumatoid arthritis patients treated with anti-tumour necrosis factor therapy: Analysis of the Australian Rheumatology Association Database (ARAD) prospective cohort study

báo cáo khoa học: "Nulliparity enhances the risk of second primary malignancy of the breast in a cohort of women treated for thyroid cancer"

Báo cáo y học: "Is there an association between anti-TNF monoclonal antibody therapy in rheumatoid arthritis and risk of malignancy and serious infection"

Genetic mutational analysis of pediatric acute lymphoblastic leukemia from a single center in China using exon sequencing

Treatment outcomes and prognostic factors for non- malignancy associated secondary hemophagocytic lymphohistiocytosis in children

Development of prognostic signatures for intermediate-risk papillary thyroid cancer
Đã phát hiện trình chặn quảng cáo AdBlock
Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.